American Airlines To Rally Around 42%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

HC Wainwright & Co. boosted the price target for Avadel Pharmaceuticals plc AVDL from $21 to $25. HC Wainwright & Co. analyst Oren Livnat maintained a Buy rating. Avadel Pharmaceuticals shares gained 17.6% to close at $16.13 on Monday. See how other analysts view this stock.
Barclays cut the price target for Noble Corporation plc NE from $61 to $59. Barclays analyst Eddie Kim maintained an Overweight rating. Noble shares fell 0.8% to close at $43.02 on Monday. See how other analysts view this stock.
TD Cowen lowered Anheuser-Busch InBev SA/NV BUD price target from $67 to $65. TD Cowen analyst Vivien Azer maintained an Outperform rating. Anheuser-Busch InBev shares fell 0.1% to close at $60.10 on Monday. See how other analysts view this stock.
JP Morgan boosted the price target for Sea Limited SE from $43 to $70. JP Morgan analyst Ranjan Sharma upgraded Sea from Neutral to Overweight. Sea shares gained 5.6% to close at $53.90 on Monday. See how other analysts view this stock.
Needham increased Viant Technology Inc. DSP price target from $10 to $12. Needham analyst Laura Martin maintained a Buy rating. Viant Technology shares gained 1.3% to close at $9.18 on Monday. See how other analysts view this stock.
Bernstein boosted the price target for American Airlines Group Inc. AAL from $20 to $21. Bernstein analyst David Vernon maintained an Outperform rating. American Airlines shares fell 5.4% to close at $14.81 on Monday. See how other analysts view this stock.
UBS slashed The Chemours Company CC price target from $37 to $21. UBS analyst Joshua Spector downgraded the stock from Buy to Neutral. Chemours shares fell 2.8% to close at $20.19 on Monday. See how other analysts view this stock.
Keybanc boosted Veeva Systems Inc. VEEV price target from $232 to $250. Keybanc analyst Scott Schoenhaus maintained an Overweight rating. Veeva shares climbed 1.8% to close at $226.00 on Monday. See how other analysts view this stock.
Chardan Capital increased Avidity Biosciences, Inc. RNA price target from $23 to $33. Chardan Capital analyst Keay Nakae maintained a Buy rating. Avidity Biosciences shares fell 6.2% to close at $18.86 on Monday. See how other analysts view this stock.
B. Riley Securities cut Genesco Inc. GCO price target from $43 to $31. B. Riley Securities analyst Jeff Lick downgraded the stock from Buy to Neutral. Genesco shares fell 1% to close at $31.40 on Monday. See how other analysts view this stock.